| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia
|
Wallace, Danielle S.
|
|
|
7 |
11 |
p. 2496-2503
|
artikel
|
| 2 |
A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation
|
Wang, Chen
|
|
|
7 |
11 |
p. 2590-2605
|
artikel
|
| 3 |
A novel comorbidity score for older adults with non-Hodgkin lymphoma: the 3-factor risk estimate scale
|
Gordon, Max J.
|
|
|
7 |
11 |
p. 2632-2642
|
artikel
|
| 4 |
A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy
|
Hirayama, Alexandre V.
|
|
|
7 |
11 |
p. 2479-2493
|
artikel
|
| 5 |
ASCT vs CART for patients with relapsed LBCL in PR: role of TMTV
|
Strati, Paolo
|
|
|
7 |
11 |
p. 2586-2589
|
artikel
|
| 6 |
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia
|
Irani, Yazad D.
|
|
|
7 |
11 |
p. 2364-2374
|
artikel
|
| 7 |
Ay C, Pabinger I, Kovacevic KD, et al. The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease. Blood Adv. 2022;6(18):5467-5476.
|
|
|
|
7 |
11 |
p. 2656
|
artikel
|
| 8 |
Balancing considerations and qualifying conclusions for cost-effectiveness of therapies for relapsed/refractory follicular lymphoma
|
Potnis, Kunal C.
|
|
|
7 |
11 |
p. 2573-2574
|
artikel
|
| 9 |
Basal type I interferon signaling has only modest effects on neonatal and juvenile hematopoiesis
|
Li, Yanan
|
|
|
7 |
11 |
p. 2609-2621
|
artikel
|
| 10 |
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany
|
Bader, Peter
|
|
|
7 |
11 |
p. 2436-2448
|
artikel
|
| 11 |
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation
|
Iland, Harry J.
|
|
|
7 |
11 |
p. 2580-2585
|
artikel
|
| 12 |
Clinical and epidemiological features of paroxysmal cold hemoglobinuria: a systematic review
|
Jacobs, Jeremy W.
|
|
|
7 |
11 |
p. 2520-2527
|
artikel
|
| 13 |
Comparison of the effectiveness and safety of direct oral anticoagulants: a nationwide propensity score–weighted study
|
Ingason, Arnar B.
|
|
|
7 |
11 |
p. 2564-2572
|
artikel
|
| 14 |
Dasatinib-induced spleen contraction leads to transient lymphocytosis
|
Marcos-Jiménez, Ana
|
|
|
7 |
11 |
p. 2418-2430
|
artikel
|
| 15 |
Editorial Board
|
|
|
|
7 |
11 |
p. i
|
artikel
|
| 16 |
Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells
|
Pan, Feng
|
|
|
7 |
11 |
p. 2504-2519
|
artikel
|
| 17 |
Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis
|
Gooptu, Mahasweta
|
|
|
7 |
11 |
p. 2309-2316
|
artikel
|
| 18 |
Front Matter
|
|
|
|
7 |
11 |
p. ii
|
artikel
|
| 19 |
Genomics of PDGFR-rearranged hypereosinophilic syndrome
|
Rheinbay, Esther
|
|
|
7 |
11 |
p. 2558-2563
|
artikel
|
| 20 |
High BM plasma S100A8/A9 is associated with a perturbed microenvironment and poor prognosis in myelodysplastic syndromes
|
Wang, Yu-Hung
|
|
|
7 |
11 |
p. 2528-2533
|
artikel
|
| 21 |
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma
|
Epperla, Narendranath
|
|
|
7 |
11 |
p. 2287-2296
|
artikel
|
| 22 |
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
|
van Doesum, Jaap A.
|
|
|
7 |
11 |
p. 2645-2655
|
artikel
|
| 23 |
Lower incidence of chronic GVHD observed after transplantation with cryopreserved unrelated allogeneic stem cells
|
Maurer, Katie
|
|
|
7 |
11 |
p. 2431-2435
|
artikel
|
| 24 |
Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies
|
Chang, Andres
|
|
|
7 |
11 |
p. 2459-2462
|
artikel
|
| 25 |
Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis
|
Flora, Gagan D.
|
|
|
7 |
11 |
p. 2347-2359
|
artikel
|
| 26 |
Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma
|
Gribben, John
|
|
|
7 |
11 |
p. 2494-2495
|
artikel
|
| 27 |
On a collision course: SARS-CoV-2 variants and CAR T cells
|
Auletta, Jeffery J.
|
|
|
7 |
11 |
p. 2643-2644
|
artikel
|
| 28 |
Pegcetacoplan controls hemolysis in complement inhibitor–naive patients with paroxysmal nocturnal hemoglobinuria
|
Wong, Raymond Siu Ming
|
|
|
7 |
11 |
p. 2468-2478
|
artikel
|
| 29 |
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates
|
Saliba, Antoine N.
|
|
|
7 |
11 |
p. 2360-2363
|
artikel
|
| 30 |
pH-dependent conformation of multimeric von Willebrand factor
|
Smith, Ian W.
|
|
|
7 |
11 |
p. 2554-2557
|
artikel
|
| 31 |
Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas
|
Lynch, Ryan C.
|
|
|
7 |
11 |
p. 2449-2458
|
artikel
|
| 32 |
Racial and socioeconomic disparities in CLL/SLL: analysis of SEER data from 2006 to 2019
|
Kittai, Adam S.
|
|
|
7 |
11 |
p. 2575-2579
|
artikel
|
| 33 |
Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results
|
Jaeger, Ulrich
|
|
|
7 |
11 |
p. 2283-2286
|
artikel
|
| 34 |
Salvage polatuzumab and allogeneic transplant rescue patients with B-cell lymphoma failing CAR T-cell therapy
|
Furqan, Fateeha
|
|
|
7 |
11 |
p. 2463-2467
|
artikel
|
| 35 |
SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia
|
Marrero, Richard J.
|
|
|
7 |
11 |
p. 2538-2550
|
artikel
|
| 36 |
Severe autoimmune intravascular hemolytic anemia in patients receiving alemtuzumab for multiple sclerosis
|
Sharma, Parth
|
|
|
7 |
11 |
p. 2534-2537
|
artikel
|
| 37 |
SGK1 inhibition induces fetal hemoglobin expression and delays polymerization in sickle erythroid cells
|
Hara, Yannis
|
|
|
7 |
11 |
p. 2317-2323
|
artikel
|
| 38 |
Structural connectivity mediates the relationship between blood oxygenation and cognitive function in sickle cell anemia
|
Clayden, Jonathan D.
|
|
|
7 |
11 |
p. 2297-2308
|
artikel
|
| 39 |
Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome
|
DiNardo, Courtney D.
|
|
|
7 |
11 |
p. 2378-2387
|
artikel
|
| 40 |
The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?
|
Gamal, Wael
|
|
|
7 |
11 |
p. 2401-2417
|
artikel
|
| 41 |
Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation
|
Parunov, Leonid A.
|
|
|
7 |
11 |
p. 2622-2631
|
artikel
|
| 42 |
Transfusion therapy for sickle cell disease: what’s new?
|
Chou, Stella T.
|
|
|
7 |
11 |
p. 2551-2553
|
artikel
|
| 43 |
Tumor-expressed factor VII is associated with survival and regulates tumor progression in breast cancer
|
Kroone, Chantal
|
|
|
7 |
11 |
p. 2388-2400
|
artikel
|
| 44 |
Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19
|
Weiss, Lukas J.
|
|
|
7 |
11 |
p. 2324-2338
|
artikel
|
| 45 |
Under-representation of classical hematology training on hematology-oncology fellowship program websites in the United States
|
Panwar, Puja
|
|
|
7 |
11 |
p. 2375-2377
|
artikel
|
| 46 |
Underweight children older than 5 years with sickle cell anemia are at risk for early mortality in a low-resource setting
|
Klein, Lauren J.
|
|
|
7 |
11 |
p. 2339-2346
|
artikel
|
| 47 |
Use of multiple urinary biomarkers for the early detection of chronic kidney disease in sickle cell anemia
|
Castro-Sesquen, Yagahira E.
|
|
|
7 |
11 |
p. 2606-2608
|
artikel
|
Tijdschrift beschrijving